Herantis Pharma to Participate in Investor and Partnering Conferences
Herantis Pharma Plc, Press Release, 2 May 2022 at 11:15 EEST Herantis Pharma Plc (“Herantis”), developing disease modifying therapies for Parkinson’s disease, today announced that members of the Herantis management team will be attending and holding 1x1 meetings with investors and pharmaceutical companies at the following conferences: Nordic Health Summit Japan (Virtual) Herantis will participate in the Nordic Pitch Showcase session. 1x1 meetings will be scheduled during May 11-13, 2022 Inderes Investment Day May 23, 2022 The presentation will be